Pulmicort respules 0.5 mg








Pulmicort Respules (Budesonide Inhalation Suspension) Drug

11/19/2014
10:29 | Author: Steven Lewis

Pulmicort respules 0.5 mg
Pulmicort Respules (Budesonide Inhalation Suspension) Drug

Three dose strengths are available in single-dose ampules (Respules ampules): 0.25 mg, 0.5 mg, and 1 mg per 2 mL RESPULES ampule. For PULMICORT.

Visit the FDA MedWatch website or call 1-800-FDA-1088. You are encouraged to report negative side effects of prescription drugs to the FDA.

If you have switched from a corticosteroid taken by mouth (such as.

Read All Potential Side Effects and See Pictures of Pulmicort Respules »

Its partition coefficient between octanol and water at pH 7.4 is 1.6 x 103. Budesonide is a white to off-white, tasess, odorless powder that is practically insoluble in water and in heptane, sparingly soluble in ethanol, and freely soluble in chloroform.

FDA to Complete Phase-out of Chlorofluorocarbon Inhalers »

Before using this medication, l your doctor or pharmacist your medical history, especially of: eye disease (such as cataracts, glaucoma), high blood pressure, liver disease, thyroid problems, diabetes, stomach/intestinal problems (such as diverticulitis, ulcer), bone loss (osteoporosis), current/past infections (such as tuberculosis, positive tuberculosis test, herpes, fungal), bleeding problems, mental/mood conditions (such as psychosis, anxiety, depression).

Call your doctor at once if you have any of these serious side effects:

Read All Potential Precautions of Pulmicort Respules »

Here is a collection of user reviews for the medication Pulmicort Respules sorted by most helpful.

Improve treatments & prevent attacks.

For PULMICORT RESPULES (budesonide inhalation suspension), like all other nebulized treatments, the amount delivered to the lungs will depend on patient factors, the jet nebulizer utilized, and compressor performance.

Comments (1)Read more



PULMICORT RESPULES 0.5MG2ML

11/18/2014
08:02 | Author: Chloe Allen

Pulmicort respules 0.5 mg
PULMICORT RESPULES 0.5MG2ML

Patient information for PULMICORT RESPULES 0.5MG/2ML Including dosage instructions and possible side effects.

Active substance: BUDESONIDE Expand view ⇕

Terms of Use · Privacy Policy.

Source: Medicines and Healthcare Products Regulatory Agency.

To view content sources and attributions, refer to our editorial policy. Data sources include Micromedex (updated Sep 26th, 2014), Cerner Multum (updated Oct 16th, 2014), Wolters Kluwer (updated Oct 9th, 2014) and others.

This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products.

Drug information contained herein may be time sensitive. Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. More FDA updates. This information has been compiled for use by healthcare practitioners and consumers in the United States.

We comply with the HONcode standard for trustworthy health information. Verify here.

Follow: Google+ Facebook Twitter YouTube RSS.

Comments (0)

Pulmicort Respules 0.5mg - Summary of Product Characteristics (SPC)

9/17/2014
06:53 | Author: Molly Young

Pulmicort respules 0.5 mg
Pulmicort Respules 0.5mg - Summary of Product Characteristics (SPC)

Pulmicort Respules contain the potent, non-halogenated, corticosteroid, budesonide, for use in bronchial asthma, in patients where use of a.

Pharmaceutical form Sterile nebuliser suspension. Pulmicort Respules 0.5 mg, nebuliser suspension 2. An air-flow rate of 6 - 8 litres per minute through the device should be employed. Bronchial asthma. For excipients, see 6.1. The dosage of Pulmicort Respules should be adjusted to the need of the individual. 4. White to off-white suspension in plastic single dose units. Each 2 ml Respule contains 0.5 mg of budesonide. The dose delivered to the patient varies depending on the nebulising equipment used.

Comments (3)Read more

Pulmicort Respules(budesonide inhalation suspension)0.25 mg

7/16/2014
04:24 | Author: Allison King

Pulmicort respules 0.5 mg
Pulmicort Respules(budesonide inhalation suspension)0.25 mg

The efficacy of PULMICORT RESPULES at doses of 0.25 mg, 0.5 mg, and 1 mg once daily was evaluated in 344 pediatric patients, 12 months to 8 years of age.

Studies in asthmatic patients have shown a favorable ratio between topical anti-inflammatory activities and systemic corticosteroid effects over a wide dose range of inhaled budesonide in a variety of formulations and delivery systems including Pulmicort Turbuhaler (an inhalation-driven, multi-dose dry powder inhaler) and the inhalation suspension for nebulization. This is explained by a combination of a relatively high local anti-inflammatory effect, extensive first pass hepatic degradation of orally absorbed drug (85-95%) and the low potency of metabolites (see below).

Patients Previously Maintained on Inhaled Corticosteroids.

No unchanged budesonide was detected in the urine.

Comments (4)Read more

PULMICORT RESPULES (Budesonide) dosage, indication - MPR

5/15/2014
02:15 | Author: Molly Young

Pulmicort respules 0.5 mg
PULMICORT RESPULES (Budesonide) dosage, indication - MPR

PULMICORT RESPULES (Budesonide) drug information & product Budesonide (micronized) 0.25mg/2mL, 0.5mg/2mL, 1mg/2mL; susp for inhalation.

Caution with CYP3A4 inhibitors (eg, ketoconazole).

Pregnancy (Cat.B). Transferring from oral corticosteroids: see literature. Nursing mothers: not recommended. Adrenal insufficiency may occur when transferring patients from systemic corticosteroids to inhaled corticosteroids: see literature. Infections. Monitor for growth suppression in children. If exposed to chickenpox or measles, consider antiinfective prophylactic therapy. Maintain regular regimen. Post-op or during stress: monitor adrenal response. Monitor for hypercorticism and HPA axis suppression (if occur discontinue gradually).

Generic Name and Formulations: Budesonide (micronized) 0.25mg/2mL, 0.5mg/2mL, 1mg/2mL; susp for inhalation. Company: AstraZeneca Pharmaceuticals.

Not for primary treatment of acute attack.

Select the drug indication to add to your list.

Flexhaler (90mcg/dose)—1 (60 inh); Flexhaler (180mcg/dose)—1 (120 inh); Respules—30.

Only 4 drugs may be compared at once.

Previously on oral corticosteroids: 1mg/day once daily or in 2 divided doses. Previously on inhaled corticosteroids: 0.5mg/day once daily or in 2 divided doses; max 1mg/day. 6–12months: see literature. 12months–8yrs: Previously on bronchodilators alone: 0.5mg/day once daily or in 2 divided doses (if symptomatic and unresponsive to nonsteroidal therapy, may start at 0.25mg once daily). Use jet nebulizer; do not mix with other drugs. PULMICORT FLEXHALER Steroid. Rinse mouth and face (if face mask used) after use. <6months: not recommended.

Maintenance treatment of asthma and as prophylactic therapy. Use Flexhaler.

Pulmicort Respules: Respiratory or other infection, GI upset, moniliasis, fatigue, cough, dysphonia, rash, epistaxis, hypersensitivity reactions (discontinue if occurs). Pulmicort Flexhaler: nasal congestion, allergic rhinitis, viral upper respiratory tract infection, oral candidiasis, viral gastroenteritis, nausea, bronchospasm (rare).

Comments (0)